Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9943204 | The American Journal of Pathology | 2005 | 9 Pages |
Abstract
The signal transducer and activator of transcription (Stat)-1 mediates growth arrest and apoptosis. We postulated that lung fibrosis characterized by excessive proliferation of lung fibroblasts would be enhanced in Stat1-deficient (Stat1â/â) mice. Two weeks after bleomycin aspiration (3 U/kg), Stat1â/â mice exhibited a more severe fibroproliferative response and significantly elevated total lung collagen compared to wild-type mice. Growth factors [epidermal growth factor (EGF) or platelet-derived growth factor (PDGF)] enhanced [3H]thymidine uptake in lung fibroblasts isolated from Stat1â/â mice compared to wild-type mice. Interferon (IFN)-γ, which signals growth arrest via Stat1, inhibited EGF- or PDGF-stimulated mitogenesis in wild-type fibroblasts but enhanced [3H]thymidine uptake in Stat1â/â fibroblasts. Moreover, IFN-γ treatment in the absence of growth factors induced a concentration-dependent increase in [3H]thymidine uptake in Stat1â/â but not wild-type fibroblasts. Mitogen-activated protein kinase (ERK-1/2) phosphorylation in response to PDGF or EGF did not differ among Stat1â/â and wild-type fibroblasts. However, Stat3 phosphorylation induced by PDGF, EGF, or IFN-γ increased twofold in Stat1â/â fibroblasts compared to wild-type fibroblasts. Our findings indicate that Stat1â/â mice are more susceptible to bleomycin-induced lung fibrosis than wild-type mice due to 1) enhanced fibroblast proliferation in response to growth factors (EGF and PDGF), 2) stimulation of fibroblast growth by a Stat1-independent IFN-γ signaling pathway, and 3) increased activation of Stat3.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Dianne M. Walters, Aurita Antao-Menezes, Jennifer L. Ingram, Annette B. Rice, Abraham Nyska, Yoshiro Tani, Steven R. Kleeberger, James C. Bonner,